Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1676 - 1700 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Umeclidinium	cdr_SR0422_Incruse-Ellipta.pdf SR0422_Incruse_Ellipta_Sept-22-15.pdf SR0422_Incruse_Ellipta_CL_Report.pdf SR0422_Incruse_Ellipta_PE_Report.pdf	Mar 4, 2015	Reimbursement Review	Complete	SR0422-000
Solifenacin succinate / tamsulosin hydrochloride	cdr_SR0424_VesiFlow.pdf	Mar 2, 2015	Reimbursement Review	Withdrawn	SR0424-000
Aclidinium bromide/formoterol fumarate dihydrate	cdr_SR0423_Duaklir_Genuair.pdf SR0423_Duaklir_Genuair_Sept-22-15-e.pdf SR0423_DuaklirGenuair_PI.pdf SR0423_DuaklirGenuair_FDC_Report.pdf	Feb 24, 2015	Reimbursement Review	Complete	SR0423-000
Tocilizumab	cdr_SR0374_Actemra SC.pdf cdr_complete_SR0374_Actemra_SC_Feb-23-15.pdf SR0374_ActemraSC_CL_Report.pdf SR0374_ActemraSC_PE_Report.pdf SR0374_Actemra SC_PI_Submissions.pdf	Feb 23, 2015	Reimbursement Review	Complete	SR0374-000
Arzerra for Chronic Lymphocytic Leukemia - Details	pcodr_profund_ofatumumab_arzerra_cll.pdf pcodr-arzerra-cll-fn-rec.pdf pcodr-arzerra-cll-fn-cgr.pdf pcodr-arzerra-cll-fn-egr.pdf pcodr-arzerra-cll-in-rec.pdf pcodr-arzerra-cll-pagfdk.pdf pcodr-arzerra-cll-fdk-gsk.pdf pcodr-arzerra-cll-coi-llsc.pdf pcodr-arzerra-cll-coi-cllpag.pdf	Feb 23, 2015	Reimbursement Review	Complete	PC0038-000
Vedolizumab	cdr_SR0421_Entyvio.pdf SR0421_cdr_complete_Entyvio_Nov-2-15_e.pdf SR0421_Entyvio_CL_Report.pdf SR0421_Entyvio_PE_Report.pdf SR0421_Entyvio_PI_Submissions.pdf	Feb 20, 2015	Reimbursement Review	Complete	SR0421-000
Asunaprevir	SR0418 Sunvepra.pdf SR0418_complete_Sunvepra_Jul-20_16.pdf SR0418_Sunvepra_CL_Report.pdf SR0418_Sunvepra_PE_Report.pdf SR0418_Sunvepra_PI_Submissions.pdf	Feb 13, 2015	Reimbursement Review	Complete	SR0418-000
Daclatasvir	cdr_SR0417_Daklinza.pdf SR0417_cdr_complete_Daklinza_Sept-23-15_e.pdf SR0417_Daklinza_CL_Report.pdf SR0417_Daklinza_PE_Report.pdf SR0417 Daklinza_PI_Submissions.pdf	Feb 13, 2015	Reimbursement Review	Complete	SR0417-000
Eculizumab	cdr_SF0416_Soliris.pdf cdr-advice-Soliris-aHUS-June-2-2015.pdf SF0416_Soliris_aHUS_RfA_Report.pdf	Feb 9, 2015	Reimbursement Review	Complete	SF0416-000
Palonosetron	cdr_SR0415_Aloxi.pdf	Feb 6, 2015	Reimbursement Review	Withdrawn	SR0415-000
Tedizolid phosphate	cdr_SR0413_Sivextro.pdf	Jan 16, 2015	Reimbursement Review	Withdrawn	SR0413-000
Yervoy for First Line Advanced Melanoma - Details	pcodr_profund_ipilimumab_yervoy_melanoma1stline.pdf pcodr-yervoy1st-fn-rec.pdf pcodr-yervoy1stsub-fn-cgr.pdf pcodr-yervoy1stsub-fn-egr.pdf pcodr-yervoy1stsub-in-rec.pdf pcodr-yervoy1stsub-pagfdk.pdf pcodr-yervoy1stsub-bms.pdf pcodr-yervoy1st-mncfdk.pdf pcodr-yervoy1st-coi-mnc.pdf	Jan 15, 2015	Reimbursement Review	Complete	PC0042-000
Propranolol	cdr_SR0411_Hemangiol.pdf	Dec 23, 2014	Reimbursement Review	Withdrawn	SR0411-000
Linaclotide	cdr_SR0409_Constella.pdf SR0409_Constella_ Sept_25-15.pdf SR0409_Constella_CL_Report.pdf SR0409_Constella_PE_Report.pdf SR0409_Constella_PI_Submissions.pdf	Dec 17, 2014	Reimbursement Review	Complete	SR0409-000
Azelastine HCl and fluticasone propionate	cdr_SR0408_Dymista.pdf cdr_complete_SR0408_Dymista_June-19-2015.pdf SR0408_Dymista_CL_Report.pdf SR0408_Dymista_PE_Report.pdf SR0408_Dymista_PI_Submissions.pdf	Dec 9, 2014	Reimbursement Review	Complete	SR0408-000
Secukinumab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SR0407_Cosentyx.pdf SR0407_Cosentyx_Oct-30-15.pdf SR0407_Cosentyx_CL_Report.pdf SR0407_Cosentyx_PE_Report.pdf SR0407_Cosentyx_PI_Submissions.pdf	Dec 8, 2014	Reimbursement Review	Complete	SR0407-000
Ombitasvir/paritaprevir/ritonavir and dasabuvir	SR0406 Holkira Pak.pdf SR0406-Holkira-Pak-July-22-15-e.pdf SR0406_HolkiraPak_CL_Report.pdf SR0406_HolkiraPak_PE_Report.pdf SR0406_HolkiraPak_PI_Submissions.pdf	Dec 3, 2014	Reimbursement Review	Complete	SR0406-000
Alemtuzumab	cdr_SR0405_Lemtrada.pdf cdr-complete-SR0405-Lemtrada-June-22-2015.pdf SR0405_Lemtrada_RRMS_CL_Report.pdf SR0405_Lemtrada_RRMS_PE_Report.pdf SR0405 Lemtrada_RRMS_PI_Submissions.pdf	Nov 27, 2014	Reimbursement Review	Complete	SR0405-000
Fampridine	cdr_SR0404_Fampyra.pdf	Nov 6, 2014	Reimbursement Review	Withdrawn	SR0404-000
Brinzolamide / brimonidine	cdr_SR0403_Simbrinza.pdf cdr_complete_SR0403_Simbrinza_June-19_2015.pdf SR0403_Simbrinza_PI_Submissions.pdf SR0403_Simbrinza_FDC_Review_Report.pdf	Nov 3, 2014	Reimbursement Review	Complete	SR0403-000
Vortioxetine	cdr_SR0402_Trintellix.pdf	Oct 31, 2014	Reimbursement Review	Withdrawn	SR0402-000
Aflibercept	cdr_SR0401_Eylea_CRVO.pdf cdr_complete_SR0401_Eylea-CRVO_May-11-15.pdf SR0401_EyleaCRVO_CL_Report.pdf SR0401_EyleaCRVO_PE_Report.pdf SR0401_EyleaCRVO_PI_Submissions.pdf	Oct 17, 2014	Reimbursement Review	Complete	SR0401-000
Apremilast	cdr_SR0400_Otezla.pdf SR0400-Otezla-Aug-10-15-e.pdf SR0400_Otezla_CL_Report.pdf SR0400_Otezla_PE_Report.pdf	Oct 8, 2014	Reimbursement Review	Complete	SR0400-000
Abraxane for Metastatic Pancreatic Cancer - Details	pcodr_profund_nabpaclitaxel_abraxane_pc.pdf pcodr-abraxane-mpc-fn-rec.pdf pcodr-abraxane-mpc-fn-cgr.pdf pcodr-abraxane-mpc-fn-egr.pdf pcodr-abraxane-mpc-in-rec.pdf pcodr-abraxane-mpc-pag-fdk.pdf pcodr-abraxane-mpc-fdk-celgene.pdf pcodr-abraxane-mpc-coi-pcc.pdf pcodr-abraxane-mpc-coi-cc.pdf	Oct 8, 2014	Reimbursement Review	Complete	PC0037-000
Treanda-Rituximab for Chronic Lymphocytic Leukemia - Details		Sep 26, 2014	Reimbursement Review	Withdrawn	PC0040-000